Negative control elements of the cell cycle in human tumors

Current Opinion in Cell Biology

Volumn 10, Issue 6, 1998, Pages 791-797

  Adams, Peter D ^a   Kaelin Jr, William G ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CRYSTAL STRUCTURE; DNA DAMAGE; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0031797414     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(98)80123-3     Document Type: Article

References (66)

1. Planas-Silva MD, Weinberg RA. The restriction point and control of cell proliferation. Curr Opin Cell Biol. 9:1997;768-772.
2. Gottlieb TM, Oren M. p53 in growth control and neoplasia. Biochim Biophys Acta. 1287:1996;77-102.
3. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
4. Taya Y. RB kinases and RB-binding proteins: new points of view. Trends Biochem Sci. 22:1997;14-17.
5. Sellers WR, Kaelin WG Jr. Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol. 15:1997;3301-3312.
6. Lee J-O, Russo AA, Pavletich NP. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. of outstanding interest Nature. 391:1998;859-865 This paper provides structural insight into a number of aspects of pRB function and its inactivation through phosphorylation, mutation and binding of viral oncoproteins. It also pin-points the interaction site for LxCxE proteins and suggests a second site for E2F family members. Finally, it places pRB firmly in the camp of proteins that contain cyclin folds that function as protein - protein interaction domains, along with cyclin A and TFIIB.
7. Kim HY, Cho Y. Structural similarity between the pocket region of retinoblastoma tumour suppressor and the cyclin-box. Nature Struct Biol. 4:1997;390-395.
8. Gibson TJ, Thompson JD, Blocker A, Kouzarides T. Evidence for a protein domain superfamily shared by the cyclins, TFIIB and pRB/p107. Nucleic Acids Res. 22:1994;946-952.
9. Wu EW, Clemens KE, Heck DV, Munger K. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol. 67:1993;2402-2407.
10. Ikeda M-A, Nevins J. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol Cell Biol. 13:1993;7029-7035.
11. Chow KN, Dean DC. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol. 16:1996;4862-4868.
12. Kitagawa M, Higashi H, Jung H-K, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Seqawa K, Yoshida E, Nishimura S, Taya Y. The consensus motif for phosphorylation by cyclin D1-cdk4 is different from that for phosphorylation by cyclin A/E-cdk2. EMBO J. 15:1996;7060-7069.
13. 1/S transition.
14. 1/S cyclin-dependent kinases. of outstanding interest J Biol Chem. 272:1997;12738-12746 See annotation to [13].
15. Knudsen ES, Wang JY. Differential regulation of retinoblastoma function by specific cdk phosphorylation sites. J Biol Chem. 271:1996;8313-8320.
16. Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin/cdk complexes. of special interest Mol Cell Biol. 18:1998;753-761 These two papers [16,17] provide biological support for the notion that different aspects of pRB function are regulated by distinct phosphorylation events.
17. 1/S transition and S-phase progression. of special interest Genes Dev. 12:1998;2278-2292 See annotation to [16].
18. Weintraub SJ, Prater CA, Dean DC. Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 358:1992;259-261.
19. Kuo M-H, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 20:1998;615-626.
20. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. of outstanding interest Nature. 391:1998;597-601 Together these three papers [20-22] suggest that at least one mechanism by which pRB-E2F complexes mediate transcriptional repression is through binding to a histone deacetylase activity. HDAC1 is shown to contain a functional LxCxE (in the single letter code for amino acids where x is any amino acid) motif, suggesting that it may be a target of the transforming viral oncoproteins such as SV40 T antigen, HPV E7 and Adenovirus E1a.
21. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. of outstanding interest Nature. 391:1998;601-605 See annotation to [20].
22. Luo RX, Postigio AA, Dean DC. Rb interacts with histone deacetylase to repress transcription. of outstanding interest Cell. 92:1998;463-473 See annotation to [20].
23. Cress WD, Nevins JR. A role for bent DNA structure in E2F-mediated transcription activation. Mol Cell Biol. 16:1996;2119-2127.
24. Huber HE, Goodhart PJ, Huang PS. Retinoblastoma protein reverses DNA bending by transcription factor E2F. J Biol Chem. 269:1994;6999-7005.
25. Yee AS, Shih HH, Tevosian SG. New perspectives on retinoblastoma family functions in differentiation. Front Biosci. 3:1998;532-547.
26. Chen PL, Riley DJ, Chen Y, Lee WH. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:1996;2794-2804.
27. 2 phases of the cell cycle. J Cell Biol. 135:1996;441-456.
28. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 72:1993;309-324.
29. Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL. pRB controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:1996;3051-3064.
30. Tevosian SG, Shih H, Mendelson KG, Sheppard KA, Paulson KE, Yee AS. HBP-1: an HMG box transcriptional repressor that is targetted by the retinoblastoma family. Genes Dev. 11:1997;383-396.
31. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, Kaelin WGJ Jr. Stable binding of E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumour cell growth. of special interest Genes Dev. 12:1998;95-106 This paper provides evidence that the induction of differentiation and cell cycle arrest by pRB are separate events. It follows from this that both pRB induced differentiation and cell cycle arrest might contribute independently to tumor suppression, and evidence for this is provided. It also follows that cell cycle arrest and differentiation are mediated by distinct molecular mechanisms and evidence for this was obtained.
32. Kubbutat MHG, Jones SN, Vousden KH. Regulation of p53 stability by mdm2. of outstanding interest Nature. 387:1997;299-303 These papers [32,33] are significant because they demonstrate that mdm2 is a key determinant of p53 stability. Since p53 activity is thought to be regulated in large part through the stability of the protein, they suggest that the signal transduction pathways that activate p53 in response to DNA damage or activation of cellular oncogenes might feed through mdm2.
33. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. of outstanding interest Nature. 387:1997;296-299 See annotation to [32].
34. Lowe SW, Ruley E. Stabilisation of the tumour suppressor p53 is induced by adenovirus E1a and accompanies apoptosis. Genes Dev. 7:1993;535-545.
35. Debbas M, White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:1993;546-554.
36. Wu X, Levine AJ. p53 and E2F1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA. 91:1994;3602-3606.
37. Hermeking H, Eick D. Mediation of c-Myc induced apoptosis by p53. Science. 265:1994;2091-2093.
38. Wagner AJ, Kokontis JM, Hay N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21WAF1/CIP1. Genes Dev. 8:1994;2817-2830.
39. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumour suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:1995;993-1000.
40. de Stanchina E, McCurrach ME, Zindy F, Shieh S-Y, Ferbeyre G, Samuelson AV, Prives C, Roussel M, Sherr CJ, Lowe SW. E1a signalling to p53 involves the p19ARF tumour suppressor. of outstanding interest Genes Dev. 12:1998;2434-2442 These papers [40,41] confirm the concepts implicit in [42-44]. That is, that a signal transduction cascade feeds through p19ARF and mdm2 to activate p53 in response to activation of oncogenes. Interestingly, [44] showed that the role of p19ARF in activation of p53 is restricted to activation by oncogenes and it is not required for activation by DNA damage. This implies that oncogenes activate p53 in a manner that is independent of any capacity that they have to cause DNA damage.
41. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. Myc signalling via the ARF tumour suppressor regulates p53-dependent apoptosis and immortalisation. of outstanding interest Genes Dev. 12:1998;2424-2433 See annotation to [40].
42. ARF and mdm2 might be responsible for stabilization of p53.
43. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, et al. The INK4a tumour suppressor gene product, p19ARF, interacts with MDM2 and neutralises MDM2's inhibition of p53. of outstanding interest Cell. 92:1998;713-723 See annotation to [42].
44. INK4a.
45. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumour suppressor with p53 and mdm2. Proc Natl Acad Sci USA. 95:1998;8292-8297.
46. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr. A mammalian cell cycle checkpoint pathway utilising p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
47. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
48. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan M. DNA damage induces phosphorylation of the amino-terminus of p53. of outstanding interest Genes Dev. 11:1997;3471-3481 This paper demonstrates that p53 becomes phosphorylated on Ser15 in response to ionizing or UV irradiation. Together with [49] it suggests that phosphorylation of p53 in response to DNA damage might inhibit degradation promoted by mdm2. This paper also shows that, at least in response to ionizing radiation, phosphorylation of Ser15 is partly dependent upon the ATM kinase.
49. Shieh SY, Ikeda m, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. of outstanding interest Cell. 91:1997;325-334 This paper demonstrates that phosphorylation of p53 on Ser15 by DNA-dependent protein kinase (DNA-PK), a kinase related to ATM, results in inhibition of mdm2 binding. Thus, phosphorylation at this site would be expected to both stabilize p53 and promote transactivation. Reference [48] suggests that ATM is required for efficient stabilization of p53, at least in response to ionizing radiation, and reference [50] suggests that DNA-PK is required for DNA-binding of and transcriptional activation by p53, but not for stabilization of p53.
50. Woo RA, McLure KG, Lees-Miller SP, Rancourt DE, Lee PWK. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. of outstanding interest Nature. 394:1998;700-704 See annotation to [49].
51. 2/M arrest. In proposing a role for 14.3.3 proteins in this checkpoint it is entirely consistent with the recent studies of others [52-54]; moreover, since 14.3.3 proteins have homologues in Schizosaccharomyces pombe in the guise of the checkpoint genes Rad24 and Rad25, it provides a point of convergence between yeast checkpoint genetics and a p53 dependent checkpoint.
52. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of cdc25C on serine-216. of special interest Science. 277:1997;1501-1505 See annotation to [51].
53. of outstanding interest Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ. Conservation of the chk1 checkpoint pathway in mammals: linkage of DNA damage to cdk regulation through cdc25. of special interest Science. 277:1997;1497-1501 See annotation to [51].
54. of outstanding interest Furnari B, Rhind N, Russell P. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. of special interest Science. 277:1997;1495-1497 See annotation to [51].
55. Walworth NC, Bernards R. Rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science. 271:1996;353-356.
56. Keegan KS, Holtzman DA, Plug AW, Christenson ER, Brainerd EE, Flaggs G, Bentley NJ, Taylor EM, Meyn MS, Moss SB, et al. The ATR and ATM protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev. 10:1996;2423-2437.
57. Zakian VA. ATM-related genes: what do they tell us about functions of the human gene? Cell. 82:1995;685-687.
58. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. of outstanding interest Cell. 90:1997;809-819 These papers [58-61] reveal the existence of the p53-related family members p73 and p51. The existence of these proteins raises important questions regarding their functional similarities and differences with respect to p53.
59. Jost CA, Marin MC, Kaelin WG Jr. p73 is a human p53-related protein that can induce apoptosis. of outstanding interest Nature. 389:1997;191-194 See annotation to [58].
60. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M, Ikawa S. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. of outstanding interest Nat Med. 4:1998;839-843 See annotation to [58].
61. Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D. A new human p53 homologue. of outstanding interest Nat Med. 4:1998;747-748 See annotation to [58].
62. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of INK4a locus in tumour suppression and cell mortality. Cell. 85:1996;27-37.
63. Harwick KG. The spindle checkpoint. Trends Genet. 14:1998;1-4.
64. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. of outstanding interest Nature. 392:1998;300-303 These two papers [64,65] are the first to suggest that proteins in the mitotic spindle assembly checkpoint pathway are targets for functional inactivation in human cancer. As such, they further extend the concept of 'tumour suppression pathways' that was initially established through the study of pRB and p53.
65. Jin D-Y, Spencer F, Jeang K-T. Human T cell leukemia virus type 1 oncoprotein tax targets the human mitotic checkpoint protein MAD1. of outstanding interest Cell. 93:1998;81-91 See annotation to [64].
66. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. of outstanding interest Nature. 389:1997;300-305 This paper describes a powerful technique (SAGE) for isolating differentially expressed mRNAs. Using this approach, the authors show that p53 activates the transcription of redox-related genes culminating in the generation of reactive oxygen species that can degrade mitochondria.